Current Evidence of 2019 Novel Coronavirus Disease (COVID-19) Ocular Transmission: A Systematic Review and Meta-Analysis

We performed a systematic review and meta-analysis of 12 studies with 1930 participants. The pooled prevalence rate of conjunctivitis/conjunctival con...

Screening druggable targets and predicting therapeutic drugs for COVID-19 via integrated bioinformatics analysis

Since the outbreak of coronavirus disease 2019 in China, numerous research institutions have invested in the development of anti-COVID-19 vaccines and...

Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2

To prevent the novel coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2, it is necessary to perform early identification and isolation...

Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2

To prevent the novel coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2, it is necessary to perform early identification and isolation...

A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma

Convalescent plasma (CP) was previously used successfully to treat SARS-CoV-1 and MERS infections. Nine out of 10 patients who have received CP outsid...

Improving Detection Efficiency of SARS-CoV-2 Nucleic Acid Testing

SARS-CoV-2 nucleic acid testing (NAT) has been routinely used for diagnosis during this pandemic. There have been concerns about its high false-negati...

Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2

SARS-CoV-2 has caused a worldwide pandemic of coronavirus disease 2019 or COVID-19. Coronaviruses generate subgenomic RNAs through a process involving...